Francesco Buccisano
Francesco Buccisano
Professore Associato Malattie del Sangue, Universitŕ Tor Vergata
Verified email at
TitleCited byYear
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management
R Stasi, ML Evangelista, E Stipa, F Buccisano, A Venditti, S Amadori
Thrombosis and haemostasis 99 (01), 4-13, 2008
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML): Presented in part at the 42nd annual meeting of the American …
G Del Poeta, A Venditti, MI Del Principe, L Maurillo, F Buccisano, ...
Blood 101 (6), 2125-2131, 2003
Clinical significance of CD38 expression in chronic lymphocytic leukemia
G Del Poeta, L Maurillo, A Venditti, F Buccisano, AM Epiceno, G Capelli, ...
Blood 98 (9), 2633-2639, 2001
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society …
A Venditti, F Buccisano, G Del Poeta, L Maurillo, A Tamburini, C Cox, ...
Blood 96 (12), 3948-3952, 2000
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta, G Sconocchia, ...
Blood 119 (2), 332-341, 2012
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia
V Gattei, P Bulian, MI Del Principe, A Zucchetto, L Maurillo, F Buccisano, ...
Blood 111 (2), 865-873, 2008
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
MI Del Principe, G Del Poeta, F Buccisano, L Maurillo, A Venditti, ...
Blood 108 (3), 853-861, 2006
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study
M Baccarani, D Cilloni, M Rondoni, E Ottaviani, F Messa, S Merante, ...
haematologica 92 (9), 1173-1179, 2007
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood 131 (12), 1275-1291, 2018
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia
G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox, A Bruno, ...
Blood 87 (5), 1997-2004, 1996
Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial
M Marchetti, G Barosi, F Balestri, G Viarengo, S Gentili, S Barulli, ...
Journal of clinical oncology 22 (3), 424-431, 2004
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia
L Maurillo, F Buccisano, MI Del Principe, G Del Poeta, A Spagnoli, ...
48th Annual Meeting of the American-Society-of-Hematology 26 (30), 4944-4951, 2008
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia
F Buccisano, L Maurillo, V Gattei, G Del Poeta, MI Del Principe, MC Cox, ...
Leukemia 20 (10), 1783, 2006
Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program
L Maurillo, A Venditti, A Spagnoli, G Gaidano, D Ferrero, E Oliva, ...
Cancer 118 (4), 1014-1022, 2012
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia
A Venditti, G Del Poeta, F Buccisano, A Tamburini, MC Cox-Froncillo, ...
Leukemia 12 (7), 1056, 1998
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult …
F Buccisano, L Maurillo, A Spagnoli, MI Del Principe, D Fraboni, ...
Blood 116 (13), 2295-2303, 2010
Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes
A Venditti, G Del Poeta, F Buccisano, A Tamburini, MC Cox, R Stasi, ...
Blood 89 (2), 621-629, 1997
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
NI Noguera, E Ammatuna, D Zangrilli, S Lavorgna, M Divona, ...
Leukemia 19 (8), 1479, 2005
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic …
MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ...
J Clin Oncol 31 (21), 2671-7, 2013
Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity
TM Kim, SH Jung, CH An, SH Lee, IP Baek, MS Kim, SW Park, JK Rhee, ...
Clinical Cancer Research 21 (19), 4461-4472, 2015
The system can't perform the operation now. Try again later.
Articles 1–20